Additionally, analyses of metabolite quantitative trait loci (meQTLs) in AMD patients and controls have revealed significant associations involving metabolites and genes such as ASPM and LIPC, underscoring the potential role of glycerophospholipid metabolism in AMD pathogenesis [153]. The gene discussed is ASPM; the disease is age-related macular degeneration.